Caldwell Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.7K Hold
76
﹤0.01% 509
2025
Q4
$51.4K Hold
76
﹤0.01% 479
2025
Q3
$48.6K Hold
76
﹤0.01% 480
2025
Q2
$40.8K Hold
76
﹤0.01% 490
2025
Q1
$31.9K Buy
76
+16
+27% +$6.95K ﹤0.01% 506
2024
Q4
$24.8K Hold
60
﹤0.01% 524
2024
Q3
$30.3K Hold
60
﹤0.01% 507
2024
Q2
$29.2K Hold
60
﹤0.01% 507
2024
Q1
$32.4K Hold
60
﹤0.01% 506
2023
Q4
$33.3K Hold
60
﹤0.01% 492
2023
Q3
$26.2K Hold
60
﹤0.01% 510
2023
Q2
$30.1K Hold
60
﹤0.01% 506
2023
Q1
$30K Hold
60
﹤0.01% 501
2022
Q4
$24.5K Hold
60
﹤0.01% 510
2022
Q3
$19.5K Hold
60
﹤0.01% 535
2022
Q2
$21K Hold
60
﹤0.01% 540
2022
Q1
$32.8K Hold
60
﹤0.01% 512
2021
Q4
$39.5K Hold
60
﹤0.01% 494
2021
Q3
$37.3K Sell
60
-120
-67% -$80.6K ﹤0.01% 486
2021
Q2
$114K Hold
180
0.01% 340
2021
Q1
$88.1K Hold
180
0.01% 364
2020
Q4
$90K Hold
180
0.01% 348
2020
Q3
$70.8K Sell
180
-220
-55% -$81.3K 0.01% 367
2020
Q2
$132K Hold
400
0.02% 290
2020
Q1
$96.9K Hold
400
0.02% 327
2019
Q4
$104K Buy
+400
New +$105K 0.02% 353

Other funds holding IDXX

Caldwell Trust's IDXX Position: Q1 2026 in Review

Caldwell Trust held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 76 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Caldwell Trust first reported a position in IDXX in Q4 2019 and has held it in 26 quarters since. The position peaked at $132K in Q2 2020. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Caldwell Trust held 76 shares of Idexx Laboratories worth $42.7K as of Q1 2026.
  • Caldwell Trust left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #509 holding.
  • Caldwell Trust first reported a position in Idexx Laboratories in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's Idexx Laboratories position peaked at $132K in Q2 2020.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.